Truncal Lesions and Age as Key Predictors in MCC Prognosis
The following is a summary of “A multivariable disease specific model enhances prognostication...
Read More
Search Physician’s Weekly
Search for articles, editorials, meeting coverage, podcasts, and more
Showing 21 - 40 of 48 results for 'Merkel cell carcinoma'
Teledermatology Comparable to In-Person Care for Diagnosing Nonmelanoma Lesions
Teledermatology allowed for effective triage and follow-up care for patients with non-melanocytic epithelial tumors and precancerous lesions.
Read MoreQ&A : Teledermatology Comparable to In-Person Care for Diagnosing Nonmelanoma Lesions
Remote dermatology visits help clinicians effectively screen and treat more patients with nonmelanoma skin cancer than is possible in face-to-face (FTF) visits, according to a systematic analysis by researchers in Europe....
Read More
Analyzing Genetic Predisposition to Early-Onset MCC
The following is a summary of “Genetic Risk Factors for Early-Onset Merkel Cell...
Read More
Radiation treatment for breast cancer may increase incidence of nonkeratinocyte skin cancer
1. Amongst a cohort of breast cancer survivors, those that were treated with radiation had a...
Read More
Enhanced MCC Recurrence Risk Estimation via Multivariable Model Integration Beyond Cancer Stage
The following is a summary of “Merkel cell carcinoma recurrence risk estimation is improved...
Read More
Elevated Risks of Recurrence & Disease-Specific Mortality With Delayed PORT for MCC
The following is a summary of “Increased risk of recurrence and disease-specific death...
Read More
Differential Control of EZH2 and its Repressive H3K27me3 Mark in MCC: A Comparison Between Polyomavirus-Positive and -Negative Cases
The following is a summary of “Distinct Regulation of EZH2 and its Repressive H3K27me3 Mark in...
Read More
Comparable Survival Rates in Primary Cutaneous MCC after MMS and WLE
The following is a summary of “No difference in survival for primary cutaneous Merkel cell...
Read MoreAdvertisement
Immunolabeling of MOC-31 Antibodies During Mohs Surgery
For a study, researchers sought to find that the antibody ber-EP4 recognizes basal cell carcinoma...
Read More
Immune Checkpoint Inhibitors and Beyond
Merkel cell carcinoma (MCC) is a kind of skin cancer that is particularly aggressive. Patients...
Read More
Medical News Forecast for November 8-14
Lynne Peterson is the Senior Writer for Trends-in-Medicine.Here is the medical news to watch for...
Read More
Skin Cancer App Fails to Identify Rare, Aggressive Cancers
THURSDAY, Oct. 14, 2021 (HealthDay News) — A direct-to-consumer machine learning model for...
Read More
Emerging therapies for rare cutaneous cancers: A systematic review.
Rare cutaneous cancers require early management given their aggressive nature; however, few...
Read More
Inherited and acquired clinical phenotypes associated with neuroendocrine tumors
An overview of neuroendocrine neoplasms and their connections with primary and secondary...
Read More
Avelumab and cetuximab as a therapeutic combination: An overview of scientific rationale and current clinical trials in cancer.
Treatment outcomes have improved with the advent of immune checkpoint inhibitors and small...
Read MoreIdentification of Polyomaviruses in Skin Cancers.
Polyomaviruses (PyVs) were initially described in animals. They have also been detected in humans with some evidence that could play a role in skin carcinogenesis.This study aimed to verify the presence of PyVs in different skin...
Read MoreIdentification of Polyomaviruses in Skin Cancers.
Polyomaviruses (PyVs) were initially described in animals. They have also been detected in humans with some evidence that could play a role in skin carcinogenesis.This study aimed to verify the presence of PyVs in different skin...
Read More
Ophthalmic Technology Assessment – Sentinel Lymph Node Biopsy for Eyelid and Conjunctival Malignancy: A report by the American Academy of Ophthalmology.
To determine the efficacy and safety of sentinel lymph node biopsy (SLNB) in the management of...
Read More
February 2019 Briefing – Pharmacy
Here are what the editors at HealthDay consider to be the most important developments in Pharmacy for February 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. FDA: Pulmonary Embolism Risk Up With Tofacitinib 10 […]
Read More